Home › Funds › Rosalind Advisors, Inc. › SLS
Rosalind Advisors, Inc. position in SLS
SELLAS LIFE SCIENCES GROUP I · Health Care
Rosalind Advisors, Inc. reported holding 618,800 shares of SLS (SELLAS LIFE SCIENCES GROUP I) in its Q3 2026 13F filing — a position valued at US$127K, representing 0.05% of its reported portfolio and ranking #36 among its reported holdings. Rosalind Advisors, Inc. has disclosed SLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rosalind Advisors, Inc.'s SLS position evolved
Rosalind Advisors, Inc. first disclosed a stake in SLS in Q2 2026 at 568,700 shares (US$2.3M). Across 2 filings, Rosalind Advisors, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 618,800 shares valued at US$127K — an increase of 50,100 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 568.70K | $2.30M | New |
| Q3 2026 | 618.80K | $127.00K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SLS and 13F data
SLS (SELLAS LIFE SCIENCES GROUP I) is a Health Care company. 104 other funds we track also report a position in SLS — the largest reported positions include Anson Funds Management LP (US$38.2M), DAGCO, INC. (US$16.5M), Sio Capital Management, LLC (US$15.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLS
- Anson Funds Management LP 3.10M sh · $38.16M · Q3 2026
- DAGCO, INC. 1.34M sh · $16.45M · Q3 2026
- Sio Capital Management, LLC 1.23M sh · $15.15M · Q3 2026
- Ikarian Capital, LLC 354.70K sh · $5.24M · Q2 2026
- Opus Capital Group, LLC 403.63K sh · $4.97M · Q3 2026
- Murchinson Ltd. 200.00K sh · $2.46M · Q3 2026
- FULCRUM WEALTH ADVISORS, LLC 85.45K sh · $1.05M · Q3 2026
- VISION FINANCIAL MARKETS LLC 57.00K sh · $701.67K · Q3 2026
- Marathon Trading Investment Management LLC 50.10K sh · $616.73K · Q3 2026
More on Rosalind Advisors, Inc.
FAQ
How long has Rosalind Advisors, Inc. held SLS?
Rosalind Advisors, Inc. has disclosed SLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Rosalind Advisors, Inc.'s current position in SLS?
As of Q3 2026, Rosalind Advisors, Inc. holds 618.80K shares of SLS (SELLAS LIFE SCIENCES GROUP I), valued at $127.00K, representing 0.05% of its reported portfolio and ranking #36.
Has Rosalind Advisors, Inc. been buying or selling SLS?
In the latest 13F filing (Q3 2026), Rosalind Advisors, Inc. increased its position in SLS.
Which other funds hold SLS?
Other major institutional holders of SLS include Anson Funds Management LP, DAGCO, INC., Sio Capital Management, LLC, among 104 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.